Twist Bioscience (TWST) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Twist Bioscience (TWST) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Twist Bioscience

· TWST

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

12.253 B

+3.82%

General

Market Cap: $12.25B
Enterprise Value: $12.01B
Shares Outstanding: 62,270,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 51.97%
Operating Margin: -31.91%
Net Profit Margin: -31.66%
FCF Margin: -21.57%
ROA: -20.33%
ROE: -29.89%
ROIC: -24.57%
Current Ratio: 2.67
Debt-to-Equity: 0.21
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -1.57
P/S: 27.87
P/FCF: —
P/B: 27.00
EV/EBITDA: -111.42

Growth

Rev 1Y: 20.32%
Rev 1Y Fwd Est: 21.19%
Rev 3Y (CAGR): 22.76%
Rev 5Y (CAGR): 33.11%
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $431.8M
Gross Margin: 51.97%
Operating Expenses: $362.16M
Operating Income: -$137.77M
Net Profit: -$136.72M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $117.44M
Working Capital: $201.04M
Total Assets: $672.44M
Net Debt: -$23.85M
Total Liabilities: $226.7M
Total Equity: $445.74M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$53.07M
Cash Flow from Investing: -$45.24M
Cash Flow from Financing: $13.8M
Free Cash Flow: -$93.12M
Capital Expenditures: $40.05M